{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:30:59Z","timestamp":1754152259742,"version":"3.41.2"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,21]]},"DOI":"10.7759\/cureus.88455","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T19:41:36Z","timestamp":1753126896000},"source":"Crossref","is-referenced-by-count":0,"title":["Exploring Prenatal Signs of Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, and Skeletal Anomalies (CLOVES) Syndrome: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Emily","family":"Henuzet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Boon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Dumitriu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leentje","family":"Peetermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Steenhaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"ISSVA classification for vascular anomalies. (2025). Accessed. July 18, 2025: http:\/\/issva.org\/classification."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s44161-023-00280-4","article-title":"A case report of sirolimus use in early fetal management of lymphatic malformation","volume":"2","author":"Seront E","year":"2023","unstructured":"Seront E, Biard JM, Van Damme A, et al.. A case report of sirolimus use in early fetal management of lymphatic malformation. Nat Cardiovasc Res. 2023, 2:595-9. 10.1038\/s44161-023-00280-4","journal-title":"Nat Cardiovasc Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.32023","article-title":"Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients","volume":"143A","author":"Sapp JC","year":"2007","unstructured":"Sapp JC, Turner JT, van de Kamp JM, van Dijk FS, Lowry RB, Biesecker LG. Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients. Am J Med Genet A. 2007, 143A:2944-58. 10.1002\/ajmg.a.32023","journal-title":"Am J Med Genet A"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MCD.0b013e328317a716","article-title":"Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of CLOVES syndrome","volume":"18","author":"Alomari AI","year":"2009","unstructured":"Alomari AI. Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of CLOVES syndrome. Clin Dysmorphol. 2009, 18:1-7. 10.1097\/MCD.0b013e328317a716","journal-title":"Clin Dysmorphol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S351637","article-title":"A review on cutaneous and musculoskeletal manifestations of CLOVES syndrome","volume":"15","author":"\u00d6zt\u00fcrk Durmaz E","year":"2022","unstructured":"\u00d6zt\u00fcrk Durmaz E, Demircio\u011flu D, Yal\u0131nay Dikmen P, et al.. A review on cutaneous and musculoskeletal manifestations of CLOVES syndrome. Clin Cosmet Investig Dermatol. 2022, 15:621-30. 10.2147\/CCID.S351637","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1051\/medsci\/2020023","article-title":"[Segmental overgrowth syndromes and therapeutic strategies]","volume":"36","author":"Venot Q","year":"2020","unstructured":"Venot Q, Canaud G. [Segmental overgrowth syndromes and therapeutic strategies]. Med Sci (Paris). 2020, 36:235-42. 10.1051\/medsci\/2020023","journal-title":"Med Sci (Paris)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2024.07.013","article-title":"Targeted treatments for vascular malformations: current state of the art","volume":"22","author":"Seront E","year":"2024","unstructured":"Seront E, Hermans C, Boon LM, Vikkula M. Targeted treatments for vascular malformations: current state of the art. J Thromb Haemost. 2024, 22:2961-75. 10.1016\/j.jtha.2024.07.013","journal-title":"J Thromb Haemost"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.173095","article-title":"Preliminary results of the European multicentric phase III trial regarding sirolimus in slow-flow vascular malformations","volume":"8","author":"Seront E","year":"2023","unstructured":"Seront E, Van Damme A, Legrand C, et al.. Preliminary results of the European multicentric phase III trial regarding sirolimus in slow-flow vascular malformations. JCI Insight. 2023, 8:e173095. 10.1172\/jci.insight.173095","journal-title":"JCI Insight"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-084614","article-title":"A phase II double-blind multicentre, placebo-controlled trial to assess the efficacy and safety of alpelisib (BYL719) in paediatric and adult patients with megalencephaly-capillary malformation polymicrogyria syndrome (MCAP): the SESAM study protocol","volume":"14","author":"Luu M","year":"2024","unstructured":"Luu M, Vabres P, Espitalier A, et al.. A phase II double-blind multicentre, placebo-controlled trial to assess the efficacy and safety of alpelisib (BYL719) in paediatric and adult patients with megalencephaly-capillary malformation polymicrogyria syndrome (MCAP): the SESAM study protocol. BMJ Open. 2024, 14:e084614. 10.1136\/bmjopen-2024-084614","journal-title":"BMJ Open"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-010-1559-0","article-title":"Perinatal clinical and imaging features of CLOVES syndrome","volume":"40","author":"Fernandez-Pineda I","year":"2010","unstructured":"Fernandez-Pineda I, Fajardo M, Chaudry G, Alomari AI. Perinatal clinical and imaging features of CLOVES syndrome. Pediatr Radiol. 2010, 40:1436-9. 10.1007\/s00247-010-1559-0","journal-title":"Pediatr Radiol"},{"key":"ref11","article-title":"Cloves syndrome: a case report and perinatal diagnostic findings","volume":"25","author":"Puvabanditsin S","year":"2014","unstructured":"Puvabanditsin S, Memon N, Chekmareva M, Di Stefano V, Mehta R. Cloves syndrome: a case report and perinatal diagnostic findings. Genet Couns. 2014, 25:265-70.","journal-title":"Genet Couns"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.36672","article-title":"Prenatal diagnosis of CLOVES syndrome confirmed by detection of a mosaic PIK3CA mutation in cultured amniocytes","volume":"164A","author":"Emrick LT","year":"2014","unstructured":"Emrick LT, Murphy L, Shamshirsaz AA, et al.. Prenatal diagnosis of CLOVES syndrome confirmed by detection of a mosaic PIK3CA mutation in cultured amniocytes. Am J Med Genet A. 2014, 164A:2633-7. 10.1002\/ajmg.a.36672","journal-title":"Am J Med Genet A"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.36836","article-title":"PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation","volume":"167A","author":"Keppler-Noreuil KM","year":"2015","unstructured":"Keppler-Noreuil KM, Rios JJ, Parker VE, et al.. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A. 2015, 167A:287-95. 10.1002\/ajmg.a.36836","journal-title":"Am J Med Genet A"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1742271X19880327","article-title":"Prenatal diagnosis of Klippel-Trenaunay syndrome: series of four cases and review of the literature","volume":"28","author":"Ivanitskaya O","year":"2020","unstructured":"Ivanitskaya O, Andreeva E, Odegova N. Prenatal diagnosis of Klippel-Trenaunay syndrome: series of four cases and review of the literature. Ultrasound. 2020, 28:91-102. 10.1177\/1742271X19880327","journal-title":"Ultrasound"},{"key":"ref15","article-title":"Proteus syndrome","author":"Biesecker LG","year":"2023","unstructured":"Biesecker LG, Sapp JC. Proteus syndrome. GeneReviews. Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (ed): University of Washington, Seattle, WA; 2023."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/383450-exploring-prenatal-signs-of-congenital-lipomatous-overgrowth-vascular-malformations-epidermal-nevi-and-skeletal-anomalies-cloves-syndrome-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T19:41:37Z","timestamp":1753126897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/383450-exploring-prenatal-signs-of-congenital-lipomatous-overgrowth-vascular-malformations-epidermal-nevi-and-skeletal-anomalies-cloves-syndrome-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.88455","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,21]]}}}